Latest News in the pharma Industry

All

Ground-breaking preclinical data to be presented at AAIC 2017

Ground-breaking preclinical data to be presented at AAIC 2017

16 Jul 2017

KalGene’s Alzheimer’s therapeutics candidate, licensed from the NRC (KAL-ABP-BBB), crosses the blood-brain barrier, and reduces amyloid-beta burden in a transgenic rat model after a 4-week treatment.

Read more 
FDA committee recommends approval of Mylan and Biocon's proposed biosimilar trastuzumab

FDA committee recommends approval of Mylan and Biocon's proposed biosimilar trastuzumab

16 Jul 2017

Vote marks first proposed biosimilar trastuzumab to be recommended by the committee.

Read more 
GSK ships 2017-18 seasonal influenza vaccines for US market

GSK ships 2017-18 seasonal influenza vaccines for US market

16 Jul 2017

Company expects to supply up to 40 million doses across both vaccines for the US market in the 2017-18 season.

Read more 
Novartis confirms 5-year data for Cosentyx reinforcing sustained efficacy and safety profile in psoriasis

Novartis confirms 5-year data for Cosentyx reinforcing sustained efficacy and safety profile in psoriasis

16 Jul 2017

Cosentyx continues to demonstrate it can provide what psoriasis patients want - a life with clear skin.

Read more 
Bosch sets standards in sterile powder filling with AFG 5000

Bosch sets standards in sterile powder filling with AFG 5000

13 Jul 2017

The system's new, variable transport system avoids bottlesnecks or delays in workflow.

Read more 
Novartis CAR-T cell therapy CTL019 recommended for FDA approval

Novartis CAR-T cell therapy CTL019 recommended for FDA approval

13 Jul 2017

A BLA for this indication is under FDA priority review; if approved, CTL019 could become first CAR-T cell therapy available.

Read more 
FDA accepts sNDA for Xeljanz for the treatment of adult patients with active ulcerative colitis

FDA accepts sNDA for Xeljanz for the treatment of adult patients with active ulcerative colitis

13 Jul 2017

Anticipated Prescription Drug User Fee Act (PDUFA) action date for the sNDA is March 2018 .

Read more 
Merck KGaA refines Western European life science production site network

Merck KGaA refines Western European life science production site network

13 Jul 2017

Company to invest €90 million and cut 200 jobs.

Read more 
Lilly reaches settlement agreement in US Cialis patent litigation

Lilly reaches settlement agreement in US Cialis patent litigation

12 Jul 2017

Cialis exclusivity is now expected to end at the earliest on 27 September 2018.

Read more 
FDA approves Blincyto to treat relapsed or refractory B-cell precursor acute lymphoblastic leukemia

FDA approves Blincyto to treat relapsed or refractory B-cell precursor acute lymphoblastic leukemia

12 Jul 2017

Blincyto is the first and only Bispecific T cell Engager (BiTE) immunotherapy to demonstrate superior overall survival versus standard of care chemotherapy.

Read more 
SMC says ‘yes’ to Opdivo for blood cancer patients

SMC says ‘yes’ to Opdivo for blood cancer patients

12 Jul 2017

Patients in Scotland will now join those in England and Wales and be able to benefit from this potentially life-extending immunotherapy on the NHS.

Read more 
Erytech collaborates with Queen’s University to advance product candidate for rare metabolic disorders

Erytech collaborates with Queen’s University to advance product candidate for rare metabolic disorders

12 Jul 2017

The collaboration will leverage the expertise of Queen’s University and Erytech’s ERYCAPS platform technology.

Read more